Clinical

What we're reading, January 1, 2016: key healthcare legal battles in 2016; study looks at the safety and outcomes of giving birth outside of the hospital; and a tool helps providers better understand the costs they incur.

A study published in the Journal of the National Cancer Institute found that ease of preparation prior to the screening test is an important determinant of colonoscopy uptake.

New data does not support the idea that aspirin has protective qualities and “down-the-road” benefits for breast cancer patients. It may, however, help reduce breast density and improve earlier detection of some breast cancers.

What we're reading, December 31, 2015: small innovations from doctors and insurers can make a big difference in cutting healthcare costs; WellCare is transitioning its pharmacy benefit management to CVS Health; and US health officials remind Americans to get the flu shot.

Most hematologic oncologists have end-of-life discussions with patients with blood cancers too late, according to a new study.

A literature review by researchers at the Abramson Cancer Center has identified a potential use of the cell cycle inhibitor palbociclib in a variety of cancers.

Studies that provided updates on new drug trials, sessions on value-based care, and the cost of healthcare, were most popular among readers of The American Journal of Managed Care.

What we're reading, December 28, 2015: patients fight for Medicaid coverage of expensive hepatitis C treatment, Express Scripts develops programs to protect insurer's from pricey new drugs, and Republicans divided over Medicaid expansion.

Historically, the biggest barrier to enrolling diverse populations in clinical trials has been a lack of establishing trusting relationships between researchers and communities and their residents, explained C. Daniel Mullins, PhD, professor in the Pharmaceutical Health Services Research Department at the University of Maryland School of Pharmacy.

This week The American Journal of Managed Care offers a special episode of highlights from the American Society of Hematology's annual meeting, including sessions on newly approved treatments, how the move to pay-for-performance affects hematologists, and the increasing role of patient-reported outcomes.

In addition to being responsible for longer hospital stays and readmissions, Clostridium difficile is increases hospital costs by 40%, according to a new study conducted by Premier, Inc.

Most senior healthcare executives agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, but a minority are happy with the current degree of transparency in their organization.

Emil Chiauzzi, PhD, research director, client services at PatientsLikeMe, sat down for an interview at the ISPOR 20th Annual International Meeting to discuss using social media for patient engagement and improving the relationships between researchers and patients.